期刊文献+

肺部给药新剂型国内外研究进展 被引量:8

Progress of new dosage forms for pulmonary drug delivery at home and abroad
原文传递
导出
摘要 近年来,肺部给药剂型在医药市场获得快速增长。随着药用辅料、给药新技术的发展,微球、纳米粒、脂质体、固体脂质纳米粒、纳米脂质载体、胶束等作为药物载体表现出良好的应用前景。本文通过查阅和分析近年来国内外发表的相关文献专利,就肺部给药新剂型的研究近况作一综述。 Dosage forms for pulmonary drug delivery in the pharmaceutical market have developed rapidly in recent years. With the development of pharmaceutical excipients and new drug delivery technologies, microspheres, nanoparticles, liposomes, solid lipid nanoparticles, nanostructured lipid carriers and micelles show a good prospect of application. By referring and analysis the recent domestic and international literatures, this paper reviewed the advances in new dasage forms for pulmonary drug delivery.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2016年第3期171-177,共7页 Chinese Journal of New Drugs and Clinical Remedies
基金 山东省科技发展计划项目(2014GZX221002)
关键词 肺部给药系统 剂型 迟效制剂 纳米技术 药物载体 pulmonary drug delivery system dosage forms delayed-action preparations nanotechnology drug carriers
  • 相关文献

参考文献42

  • 1EDWARDS DA, HANES J, CAPONETTI G, et ol. Large porous particles for pulmonary drug delivery[J]. Science, 1997, 276 (5320) : 1868-1871.
  • 2KIM H, PARK H, LEE J, et al. Highly porous large poly (lactic-co-glycolic acid) microspheres adsorbed with palmityl- acylated exendin- 4 as a long- acting inhalation system for treating diabetes[J]. Biomaterials, 2011, 32(6) : 1685-1693.
  • 3SHI XZ, LI C J, GAO S, et al. Combination of doxorubicin- based chemotherapy and polyethylenimine/p53 gene therapy for the treatment o flung cancer using porous PLGA microparticles [J]. Colloids Surf B-Biointerfaces, 2014, 122: 498-504.
  • 4SAIGAL A, NG WK, TAN RB, et ol. Development of controlled release inhalable polymeric microspheres for treatment of pulmonary hypertension[J]. Int J Pharm, 2013, 450 (1-2) : 114- 122.
  • 5PARK JH, JIN HE, KIM DD, et al. Chitosan microspheres as an alveolar macrophage delivery system of ofloxaein via pulmonary inhalation[J]. Int J Pharm, 2013, 441 (1-2): 562- 569.
  • 6TODOROFF J, VANBEVER R. Fate of nanomedicines in the lungs[J]. Curr Opin in Colloid & Interface Sci, 2011, 16(3): 246-254.
  • 7MAHAPATRO A, SINGH DK. Biodegradable nanopartieles are excellent vehicle for site directed in- vivo delivery of drugs and vaccines[J]. J Nanobiotechnology, 2011, 9: 55.
  • 8徐颖颖,蔡鑫君,叶晓莉,李颖芳,王丛瑶,李范珠.利福平聚乳酸-羟基乙酸共聚物纳米粒雾化吸入给药肺靶向性研究[J].中国现代应用药学,2013,30(7):755-758. 被引量:9
  • 9UNGARO F, D'ANGELO I, COLETTA C, eta/. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers[J]. J Control Release, 2011, 157(1): 149-159.
  • 10LAI SK, WANG YY, HANES J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues[J]. Adv Drug Deliv Rev, 2009, 61(2): 158-171.

二级参考文献34

  • 1AGRAWAL Y K, BHATTH H G, RAVAL H G, et al. Emerging trends in tuberculosis therapy [J]. J Sci lnd Res, 2007, 66(3): 191-208.
  • 2SETHI T, AGRAWAL A. Structure and function of the tuberculous lung: considerations for inhaled therapies [J]. Tuberculosis (Edinb), 2011, 91 (1): 67-70.
  • 3ZAROGOULIDIS P, CHATZAKI E, PORPODIS K, et al. Inhaled chemotherapy in lung cancer: future concept of nanomedicine [J]. Int J Nanomedicine, 2012, (7): 1551-1572.
  • 4RAO G C, KUMAR M S, MATHIVANAN N, et al. Nanosuspensions as the most promising approach in nanoparticulate drug dielivery systems [J]. Pharmazie, 2004, 59(1): 5-9.
  • 5JACOBS C, MULLER R H. Production and characterization of a budesorude nanosuspension for pulmonary adminisa'ation [J]. Pharm Res, 2002, 19(2): 189-194.
  • 6WILLIS L, HAYES D J R, MANSOUR H M. Therapeutic liposomal dry powder inhalation aerosols for targeted lung delivery [J]. Lung, 2012, 190(3): 251-262.
  • 7GOYAL P, GILL S, GUPTA U D, et al. Development and characterization of rifampicin loaded floating microspheres [J]. Artif Cells Blood Substit Immobil Biotechnol, 2011, 39(5): 330-334.
  • 8XU Y,WANG LM,HE J,et al.Prevalence and control of diabetes in Chinese adults[J].JAMA,2013,310(9):948-958.
  • 9LARKIN ME,CAPASSO VA,CHEN CL,et al.Measuring psychological insulin resistance:barriers to insulin use[J].Diabetes Educ,2008,34(3):511-517.
  • 10NEUMILLER JJ,CAMPBELL RK.Technosphere insulin:an inhaled prandial insulin product[J].Bio Drugs,2010,24(3):165-172.

共引文献19

同被引文献123

引证文献8

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部